Structure Therapeutics Stock Is Up 47%, but One Fund Just Fully Exited a $2.6 Million Position

ACT Capital Management sold 38,500 shares of Structure Therapeutics in the first quarter, with an estimated transaction value of $2.63 million based on Q1 2026 average prices. The filing is a routine ownership update and does not indicate a broader operational or fundamental change at the company. Market impact is likely limited unless accompanied by additional insider or institutional activity.

Analysis

ACT Capital Management sold 38,500 shares of Structure Therapeutics in the first quarter, with an estimated transaction value of $2.63 million based on Q1 2026 average prices. The filing is a routine ownership update and does not indicate a broader operational or fundamental change at the company. Market impact is likely limited unless accompanied by additional insider or institutional activity.